On 30 July 2009, the Commercial Court of Granada ordered an ex parte preliminary injunction against two companies that had obtained authorisation to market generics of sustained-release…
The Bulgarian Patent Office (BPO) revoked patent BG 61365 and published an announcement of the revocation in its official bulletin. The revocation was appealed by AstraZeneca Pharmaceuticals LR. The…
The Barcelona Court of Appeal confirmed a preliminary injunction ordered by Commercial Court number 4 of Barcelona on 9 June 2008 preventing the launch of several generics of Atorvastatin. One of the…
The High Court dismissed Novartis' claim for infringement of its EP(UK) patent for ophthalmically compatible extended wear contact lenses. Although Novartis established that the defendants' product…
The Brussels Court of Appeal ruled that, in calculating the period of validity of an SPC, the ‘first authorisation to place the product on the market in the Community’, within the meaning of Article…
The District Court Düsseldorf clarified its case law regarding the requirement of a complete translation of patents into the German language and how to deal with errors in such translations. Besides,…
The Administrative Law Division of the Council of State holds that the District Court has rightfully found that the Patent Office was not obligated to issue a Supplementary Protection Certificate for…
The Hague District Court nullified Sepracor's patent for compositions for treating allergic disorders using (-) cetirizine (levociterizine) on the basis of lack of inventive step. The Court…
The District Court of The Hague held that all claims of Lundbeck's escalitopram patent were invalid for lack of inventive step. The District Court nullified the patent and also called the Dutch…
